{"id":"https://openalex.org/W2979376383","doi":"https://doi.org/10.1182/blood.v124.21.638.638","title":"Alternative Splicing Is a Frequent Event and Impacts Clinical Outcome in Myeloma: A Large RNA-Seq Data Analysis of Newly-Diagnosed Myeloma Patients","display_name":"Alternative Splicing Is a Frequent Event and Impacts Clinical Outcome in Myeloma: A Large RNA-Seq Data Analysis of Newly-Diagnosed Myeloma Patients","publication_year":2014,"publication_date":"2014-12-06","ids":{"openalex":"https://openalex.org/W2979376383","doi":"https://doi.org/10.1182/blood.v124.21.638.638","mag":"2979376383"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v124.21.638.638","doi":"https://doi.org/10.1182/blood.v124.21.638.638","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.638.638","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065665275","display_name":"Naim U. Rashid","orcid":"https://orcid.org/0000-0002-7274-8259","observed_orcids":["https://orcid.org/0000-0002-7274-8259"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Naim Rashid","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073612758","display_name":"St\u00e9phane Minvielle","orcid":"https://orcid.org/0000-0003-1389-312X","observed_orcids":["https://orcid.org/0000-0003-1389-312X"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210092509","display_name":"Centre de Recherche en Canc\u00e9rologie et Immunologie Int\u00e9gr\u00e9e Nantes Angers","ror":"https://ror.org/003g1aw90","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I3019204325","https://openalex.org/I4210092509","https://openalex.org/I4210096427","https://openalex.org/I4210106090","https://openalex.org/I4210112910","https://openalex.org/I49451733","https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Stephane Minvielle","raw_affiliation_strings":["Centre de Recherche en Canc\u00e9rologie Nantes-Angers UMR Inserm 892 - CNRS 6299, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Recherche en Canc\u00e9rologie Nantes-Angers UMR Inserm 892 - CNRS 6299, Nantes, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210092509"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041002394","display_name":"Florence Magrangeas","orcid":"https://orcid.org/0000-0002-5031-3748","observed_orcids":["https://orcid.org/0000-0002-5031-3748"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210092509","display_name":"Centre de Recherche en Canc\u00e9rologie et Immunologie Int\u00e9gr\u00e9e Nantes Angers","ror":"https://ror.org/003g1aw90","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I3019204325","https://openalex.org/I4210092509","https://openalex.org/I4210096427","https://openalex.org/I4210106090","https://openalex.org/I4210112910","https://openalex.org/I49451733","https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Florence Magrangeas","raw_affiliation_strings":["Centre de Recherche en Canc\u00e9rologie Nantes-Angers UMR Inserm 892 - CNRS 6299, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Recherche en Canc\u00e9rologie Nantes-Angers UMR Inserm 892 - CNRS 6299, Nantes, France","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210092509"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041668980","display_name":"Mehmet Samur","orcid":"https://orcid.org/0000-0002-9978-5682","observed_orcids":["https://orcid.org/0000-0002-9978-5682"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehmet Kemal Samur","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052083674","display_name":"Alice Clynen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alice Clynen","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079209072","display_name":"Adam Samuel Sperling","orcid":"https://orcid.org/0000-0002-9369-4413","observed_orcids":["https://orcid.org/0000-0002-9369-4413"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Sperling","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019802024","display_name":"Yu\u2010Tzu Tai","orcid":"https://orcid.org/0000-0001-6199-3569","observed_orcids":["https://orcid.org/0000-0001-6199-3569"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu-Tzu Tai","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062468245","display_name":"Mariateresa Fulciniti","orcid":"https://orcid.org/0000-0002-1432-9742","observed_orcids":["https://orcid.org/0000-0002-1432-9742"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariateresa Fulciniti","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul G. Richardson","raw_affiliation_strings":["The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025996929","display_name":"Michel Attal","orcid":"https://orcid.org/0000-0002-0136-9665","observed_orcids":["https://orcid.org/0000-0002-0136-9665"]},"institutions":[{"id":"https://openalex.org/I4210138343","display_name":"H\u00f4pital Purpan","ror":"https://ror.org/03vcx3f97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210138343"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Michel Attal","raw_affiliation_strings":["CHU Purpan, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU Purpan, Toulouse, France","institution_ids":["https://openalex.org/I4210138343"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103143602","display_name":"Philippe Moreau","orcid":"https://orcid.org/0000-0003-1780-8746","observed_orcids":["https://orcid.org/0000-0003-1780-8746"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Moreau","raw_affiliation_strings":["CHU DE NANTES, NANTES, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU DE NANTES, NANTES, France","institution_ids":["https://openalex.org/I3019204325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050977500","display_name":"Giovanni Parmigiani","orcid":"https://orcid.org/0000-0002-8783-5961","observed_orcids":["https://orcid.org/0000-0002-8783-5961","https://orcid.org/0000-0002-4791-3072"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giovanni Parmigiani","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063422967","display_name":"Herv\u00e9 Avet\u2010Loiseau","orcid":"https://orcid.org/0000-0002-3050-0140","observed_orcids":["https://orcid.org/0000-0002-3050-0140"]},"institutions":[{"id":"https://openalex.org/I4210123497","display_name":"H\u00f4pital Rangueil","ror":"https://ror.org/034zn5b34","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210123497"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Herv\u00e9 Avet-Loiseau","raw_affiliation_strings":["CHU RANGUEIL, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CHU RANGUEIL, Toulouse, France","institution_ids":["https://openalex.org/I4210123497"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C. Munshi","raw_affiliation_strings":["LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.6469,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.74498048,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"124","issue":"21","first_page":"638","last_page":"638"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.8769999742507935,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.8769999742507935,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10604","display_name":"RNA Research and Splicing","score":0.11869999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10015","display_name":"Genomics and Phylogenetic Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alternative-splicing","display_name":"alternative splicing","score":0.9779999852180481},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/isoform-switching","display_name":"isoform switching","score":0.9049999713897705},{"id":"https://openalex.org/keywords/splice-variants","display_name":"splice variants","score":0.7649999856948853},{"id":"https://openalex.org/keywords/cd138-myeloma-cells","display_name":"CD138+ myeloma cells","score":0.7940000295639038},{"id":"https://openalex.org/keywords/mycl1","display_name":"MYCL1","score":0.6439999938011169},{"id":"https://openalex.org/keywords/cyclin-d3","display_name":"cyclin D3","score":0.9819999933242798},{"id":"https://openalex.org/keywords/mefv-gene","display_name":"MEFV gene","score":0.9309999942779541},{"id":"https://openalex.org/keywords/clinical-outcomes","display_name":"clinical outcomes","score":0.4620000123977661},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7730000019073486},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.6589999794960022},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9520000219345093},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.7889999747276306}],"concepts":[{"id":"https://openalex.org/C36823959","wikidata":"https://www.wikidata.org/wiki/Q373027","display_name":"Exon","level":3,"score":0.6994677782058716},{"id":"https://openalex.org/C194583182","wikidata":"https://www.wikidata.org/wiki/Q21114084","display_name":"Alternative splicing","level":4,"score":0.6672441959381104},{"id":"https://openalex.org/C54458228","wikidata":"https://www.wikidata.org/wiki/Q237218","display_name":"RNA splicing","level":4,"score":0.641678512096405},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.6001915335655212},{"id":"https://openalex.org/C107397762","wikidata":"https://www.wikidata.org/wiki/Q2542347","display_name":"RNA-Seq","level":5,"score":0.5592310428619385},{"id":"https://openalex.org/C2778776201","wikidata":"https://www.wikidata.org/wiki/Q3474283","display_name":"Exon skipping","level":5,"score":0.5375359654426575},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5155572891235352},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.44517266750335693},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.4430431127548218},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.43790027499198914},{"id":"https://openalex.org/C94671646","wikidata":"https://www.wikidata.org/wiki/Q207551","display_name":"Intron","level":3,"score":0.4192315638065338},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.37676307559013367},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.34637826681137085},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.34102290868759155},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.34006279706954956},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3212738633155823},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.11886447668075562}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v124.21.638.638","doi":"https://doi.org/10.1182/blood.v124.21.638.638","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v124.21.638.638","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2690457219","https://openalex.org/W2576283224","https://openalex.org/W2243699995","https://openalex.org/W3211414592","https://openalex.org/W2980355562","https://openalex.org/W2987127094","https://openalex.org/W4310099124","https://openalex.org/W4311939678","https://openalex.org/W2141117008","https://openalex.org/W2987000109"],"abstract_inverted_index":{"Abstract":[0],"Alternative":[1],"splicing":[2,15,31,224,395,464,495,595,617],"is":[3],"an":[4,599,661],"important":[5,644],"post-translational":[6,637],"change":[7,339],"that":[8,193,424],"alters":[9],"gene":[10,487,501,513,590],"function.":[11],"Misregulation":[12],"of":[13,21,64,68,88,130,175,280,324,388,393,419,485,492,512,586,615,627,633,664],"alternative":[14,30,223,394,494,616],"has":[16,350],"been":[17,351],"implicated":[18],"in":[19,32,45,115,267,311,340,358,371,454,483,497,583,618],"number":[20,279],"disease":[22],"processes":[23],"including":[24,284,406],"cancer.":[25],"Here":[26],"we":[27,165,219,460,508],"have":[28,355],"analyzed":[29,152,253],"myeloma":[33,94],"using":[34,153],"high":[35],"throughput":[36],"RNA-seq.":[37],"Our":[38],"analytic":[39],"pipeline":[40],"for":[41,55,239,383,416,625,646],"RNA-seq":[42,142],"data":[43,238,405,592,596],"used":[44],"this":[46,605],"investigation":[47],"not":[48,315,628],"only":[49,473,629],"provides":[50,59],"information":[51,60],"on":[52,61,148,187,660],"expression":[53,63,174,511,591,631],"levels":[54],"genes,":[56,472],"but":[57,635],"also":[58,220,252,636],"the":[62,116,128,199,321,341,366,490,510,543,584,589,608,623,630],"known":[65,176],"splice":[66],"variants":[67],"genes":[69,192,263,283,299,426,564,634,640],"(isoforms),":[70],"and":[71,104,132,151,157,172,203,216,230,243,254,275,290,296,349,373,411,433,444,456,523,540,612,620],"can":[72],"identify":[73],"novel":[74,98,183,222],"exon":[75,81,228,233,399],"level":[76,391,632],"events":[77,496],"across":[78],"individuals":[79],"(i.e.":[80],"skipping":[82,229],"events).":[83],"We":[84,179,259,361,422,581],"conducted":[85],"a":[86,154,182,336,356,417,474,553],"study":[87,606],"328":[89,200],"newly-diagnosed":[90],"patients":[91,516],"with":[92,97,106,256,385,528,537,571,593],"multiple":[93,467],"treated":[95],"homogeneously":[96],"agent":[99],"combination":[100],"containting":[101],"lenalidomide,":[102],"bortezomib":[103],"dexamethsone":[105],"or":[107,666],"without":[108],"high-dose":[109],"melphalan":[110],"followed":[111],"by":[112,141],"lenalidomide":[113],"maintenance":[114],"IFM/DFCI":[117],"study.":[118],"RNA":[119],"isolated":[120],"from":[121,133,210],"purified":[122],"CD138+":[123],"MM":[124,201,240,274,407,619],"cells":[125,138],"collected":[126],"at":[127],"time":[129],"diagnosis":[131],"18":[134,204],"normal":[135,276],"donor":[136],"plasma":[137],"were":[139,251,477,565],"processed":[140],"(100":[143],"million":[144],"paired":[145],"end":[146],"reads":[147],"Illumina":[149],"HiSeq)":[150],"custom":[155],"computational":[156],"statistical":[158],"pipeline.":[159],"Following":[160],"read":[161],"alignment":[162],"to":[163,168,190,309,313,347,354,365,479,499,505,530,562,597,622],"hg19,":[164],"utilized":[166],"RSEM":[167],"quantify":[169],"both":[170],"gene-level":[171],"isoform-level":[173],"ENSEMBL":[177],"transcripts.":[178],"then":[180],"implemented":[181],"testing":[184,468],"approach":[185],"based":[186],"compositional":[188],"regression":[189,556],"discover":[191],"show":[194],"significant":[195,265,305,369,428,463,569,609],"isoform":[196,269,306,325,344,429],"switching":[197,307,326,430],"between":[198,273,431,515],"samples":[202,209],"Normal":[205],"Plasma":[206],"Cell":[207],"(NPC)":[208],"healthy":[211],"donors.":[212],"Using":[213,552],"various":[214],"programs":[215],"their":[217],"modifications,":[218],"identified":[221,374,524,566,641],"events,":[225,396],"such":[226,397,436],"as":[227,245,247,398,437,567,648,650],"mutually":[231],"exclusive":[232],"usage,":[234],"among":[235],"others.":[236],"Patient":[237],"characteristics,":[241,408],"cytogenetic":[242],"FISH":[244,410],"well":[246,316,649],"clinical":[248,386,613],"survival":[249,412,573,601],"outcomes":[250,413],"correlated":[255],"genomic":[257],"data.":[258],"observed":[260],"over":[261],"600":[262],"showing":[264,320,335,368],"changes":[266,370,465],"relative":[268,342],"abundances":[270],"(isoform":[271],"switching)":[272],"samples.":[277],"A":[278],"previously":[281,352],"characterized":[282,317],"MYCL1":[285],"(adj.":[286,292,329,439,446,532,546],"p":[287,293,330,440,447,533,577],"=":[288,294,331],"0.0014)":[289],"CCND3":[291],"0.0013),":[295],"MAP":[297],"kinase-related":[298],"(MAP3K8,":[300],"MAPKAPK2,":[301],"MAPKAPK3,":[302],"MAP4K4)":[303],"exhibited":[304],"compared":[308,346,509],"normal,":[310,348],"addition":[312,498],"some":[314],"genes.":[318],"Genes":[319],"greatest":[322],"magnitude":[323],"include":[327],"MEFV":[328],"2.7":[332],"x":[333,442,449,550],"10-5),":[334],"two":[337],"fold":[338],"major":[343],"abundance":[345],"shown":[353,478],"role":[357],"lymphoid":[359],"neoplasms.":[360],"applied":[362],"hierarchical":[363],"clustering":[364],"isoforms":[367,514,526,560],"isoform-switching":[372],"4":[375,558],"distinct":[376],"clusters,":[377],"which":[378],"are":[379,401,582,643],"currently":[380,402],"being":[381],"investigated":[382],"correlation":[384,570],"subtypes":[387],"MM.":[389],"Exon":[390],"analyses":[392],"skipping,":[400],"underway.":[403],"Clinical":[404],"cytogenetics,":[409],"was":[414],"available":[415],"subset":[418,475],"265":[420],"patients.":[421],"found":[423,461],"109":[425],"showed":[427],"t(4;14)":[432],"non-t(4;14)":[434],"patients,":[435,459],"CD44":[438],"=1.8":[441],"10-6)":[443],"WHSC1":[445],"=5.1":[448],"10-28).":[450],"Comparing":[451],"del17p":[452,458],"(28":[453],"total)":[455],"non":[457],"no":[462],"after":[466],"adjustment.":[469],"Of":[470],"these":[471],"(40%)":[476],"be":[480],"differentially":[481],"expressed":[482],"terms":[484],"total":[486,500],"expression,":[488],"suggesting":[489],"importance":[491,614],"examining":[493],"expression.":[502],"With":[503],"respect":[504],"treatment":[506,531],"response,":[507],"achieving":[517],"complete":[518],"response":[519,529],"(CR)":[520],"versus":[521],"others":[522],"38":[525],"associated":[527],"value":[534,578],"<":[535,548,579],"0.05),":[536],"SEPT9,":[538],"SLC2A5,":[539],"UBX6":[541],"having":[542,568],"strongest":[544],"associations":[545],"p-value":[547],"3":[549,563],"10-4).":[551],"univariate":[554],"cox":[555,576],"model,":[557],"spliced":[559],"relating":[561],"event-free":[572],"(EFS)":[574],"(FDR-adjusted":[575],"0.05).":[580],"process":[585],"now":[587],"integrating":[588],"altered":[594],"develop":[598],"integrated":[600],"model.":[602],"In":[603],"summary,":[604],"highlights":[607],"frequency,":[610],"biological":[611],"points":[621],"need":[624],"evaluation":[626],"modifications.":[638],"The":[639],"here":[642],"targets":[645],"therapy":[647],"possible":[651],"immune":[652],"modulation.":[653],"Disclosures":[654],"Moreau:":[655],"Celgene":[656],"Corporation:":[657],"Honoraria,":[658],"Membership":[659],"entity's":[662],"Board":[663],"Directors":[665],"advisory":[667],"committees.":[668]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2019-10-18T00:00:00"}